SAN DIEGO, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization ...

One-third of the human experiments for approved drugs failed transparency requirements. Volunteers for clinical trials shouldn’t get their hopes up too high that dat...

SAN DIEGO/November 10, 2015 --(BUSINESS WIRE)--NeuroGenetic Pharmaceuticals, Inc. (NGP), a privately held biopharmaceutical company focused on Alzheimer’s disease (AD...

King of Prussia, PA/ November 9, 2015 – Greenphire, the leading provider of payment technology for the clinical trials industry, today announced the appointment of Ji...

Plymouth Meeting, PA – October 27, 2015:  CRF Health, the leading global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences ind...

The U.S. Food and Drug Administration (FDA) is seeking input from relevant stakeholders on how new technologies — including mobile health technology (mHealth), teleme...

Partnership will combine CluePoints' Risk-Based Monitoring Software with Widler & Schiemann's Consultancy Services 2 November 2015 Cambridge, MA - CluePoints, a l...